Market Tracker

04/23 8:32am ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

Tuesday’s Trading Day
70.19 +4.40 / +6.69%
Data as of Apr 22
Day’s Change
Wednesday’s Pre-Market   Switch to standard view »
70.39 +0.20 / +0.28%
 
Volume: 100.00

Today’s Trading

Previous close65.79
Today’s open66.23
Day’s range-- - --
Volume391,594
Average volume (3 months)383,620
Market cap$1.3B
Dividend yield--
Data as of 04/22/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+54.13%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+56.02%
P/E ratio163.2
Price/Sales21.82
Price/Book26.46

Competitors

 Today’s
change
Today’s
% change
INSYInsys Therapeutics I...+2.35+5.94%
AUXLAuxilium Pharmaceuti...+1.33+4.86%
PDLIPDL BioPharma Inc+0.11+1.30%
ARNAArena Pharmaceutical...+0.14+2.26%
Data as of 04/22/2014

Financials

Next reporting dateMay 7, 2014
EPS forecast (this quarter)$0.25
Annual revenue (last year)$49.0M
Annual profit (last year)$8.8M
Net profit margin18.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John L. Higgins
Chief Operating Officer &
Executive Vice President
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts